Perera, S. A., Li, D., Shimamura, T., Raso, M. G., Ji, H., Chen, L., . . . Wong, K. (2009). HER2(YVMA) drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy. National Academy of Sciences.
Citación estilo ChicagoPerera, Samanthi A., et al. HER2(YVMA) Drives Rapid Development of Adenosquamous Lung Tumors in Mice That Are Sensitive to BIBW2992 and Rapamycin Combination Therapy. National Academy of Sciences, 2009.
Cita MLAPerera, Samanthi A., et al. HER2(YVMA) Drives Rapid Development of Adenosquamous Lung Tumors in Mice That Are Sensitive to BIBW2992 and Rapamycin Combination Therapy. National Academy of Sciences, 2009.
Precaución: Estas citas no son 100% exactas.